Stay updated on CC-486 and Venetoclax for AML Clinical Trial

Sign up to get notified when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-486 and Venetoclax for AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T12:37:40.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    0.7%
    Check dated 2026-10-26T12:56:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:35:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:19:23.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page update adds a new Find contact information link and shows Revision: v3.7.0, replacing the previous Find Contact Information and Revision: v3.6.6 in the record history.
    Difference
    0.2%
    Check dated 2026-09-21T20:22:55.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    New revision v3.6.6 is added to the study record history, and the previous revision v3.6.5 is removed from the list. This reflects an update to the record's version metadata on the page.
    Difference
    0.1%
    Check dated 2026-08-31T16:25:41.000Z thumbnail image

Stay in the know with updates to CC-486 and Venetoclax for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.